How to Buy Novabridge Biosciences Stock
Novabridge Biosciences
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.
Novabridge Biosciences stock last closed at $2.38, down 0.83% from the previous day, and has increased 178.36% in one year. It has overperformed other stocks in the Biotechnology industry by 1.96 percentage points. Novabridge Biosciences stock is currently +185.71% from its 52-week low of $0.83, and -64.95% from its 52-week high of $6.79.
As of May 5, 2026, there are 265.38M shares of NBP outstanding. The market cap of NBP is $274.75M. In the past 24 hours, 1.16M NBP shares were traded.
How to Buy Novabridge Biosciences Stock
Wondering how to invest in Novabridge Biosciences stock? Here's how.
- Decide where to buy Novabridge Biosciences stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Novabridge Biosciences stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Select your method of payment and add your info.
- Research Novabridge Biosciences stock: The Novabridge Biosciences ticker symbol is NBP. Is Novabridge Biosciences stock a good investment? Should you buy shares of NBP? How do NBP's underlying business fundamentals look? Do top analysts think Novabridge Biosciences is a good buy? Why has NBP's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if NBP is a good stock to buy).
- Execute your NBP buy order: Decide if you will purchase NBP shares at the current market price or use a limit order to buy NBP stock at a given price.
- Get the latest scoop on your NBP position: Create a watchlist to watch your position in Novabridge Biosciences stock.
Step 1: Decide where to buy Novabridge Biosciences stock
You will need an online brokerage account in order to access the NASDAQ market and buy NBP shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Tech to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal information so you can invest in NBP stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create your new trading account.
- Submit your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've created your account on the best investment app, your next step is to transfer the money for your investment:
Watch the video below if you need help depositing funds into your investment account.
Step 4: Research Novabridge Biosciences stock
After you have decided on the best place to buy Novabridge Biosciences stock, it's important to evaluate their stock prior to investing, so you can comprehend the risk as well as the opportunity.
Novabridge Biosciences stock data
Novabridge Biosciences Overview
WallStreetZen was created to help everyday investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on NBP's stock page.
How is NBP stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NBP's true value.
Using relative valuations methods:
- NBP could be undervalued based on its P/B ratio of 1.19x, relative to Biotechnology industry P/B ratio of 5.01x
You can do additional valuation analysis on NBP's stock here.
NBP Financial Summary
Positive Health Checks:
- NBP has cash burn of 20557000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the NBP balance sheet.
- NBP has $210.84M in cash and short term investments. This is enough to cover its annual cash burn of $20.56M.
- There are more short-term assets than long-term liabilities on the NBP balance sheet.
- NBP has a low debt to equity ratio of 0.13.
Negative Health Checks:
- Total NBP debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy NBP stock
Out of 1 Wall Street analysts who monitor NBP, the consensus analyst rating on Novabridge Biosciences is a Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Novabridge Biosciences stock forecast page.
NBP Trading Indicators
How are NBP Revenues/Earnings doing?
Last year, NBP revenue was $0.00. Over the last 5 year, NBP's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 26.41%.
Find out more about NBP's earnings and revenue performance here.
What are NBP insiders up to?
In the last year, insiders at NBP have bought more shares than they have sold.
Mark Arnold Hagler, President and Chief Commercial Officer of NBP, was the latest NBP insider to buy. They bought $577,300.00 worth of NBP stock on Apr 24, 2026.
Learn more about who owns NBP shares here.
Does NBP provide a stable income stream?
No, Novabridge Biosciences doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your NBP buy order
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount, place a limit order.
Hit the Open button and your broker will place your order.
If you want additional info about investing in stocks on eToro, click the how to video below:
Step 6: Get the latest scoop on your NBP position
Now that you own some NBP stock, you'll want to keep up with your new investment.
Create a watchlist to monitor your NBP stock.
NBP Feed
How to Buy Stock in Novabridge Biosciences
To summarize, here are the 6 steps you need to take to buy Novabridge Biosciences stock right now:
- Decide where to buy Novabridge Biosciences stock
- Create your brokerage account
- Deposit funds into your brokerage account
- Research Novabridge Biosciences stock
- Execute your NBP buy order
- Get the latest scoop on your NBP position
If you need a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Novabridge Biosciences, hit the button below to create your watchlist.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.